Management of Scleroderma-related End-stage Renal Disease With Automated Peritoneal Dialysis

Authors

  • Malleshappa Pavan Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author
  • Ashwinikumar Aiyangar Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author
  • Anup Chaudhari Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author
  • Prashanth Rajputh Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author
  • Ravi Ranganath Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author
  • Shah Arunkumar Babulal Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India Author

Abstract

Kidney failure is the principal cause of death in scleroderma and accounts for at least 50% of deaths in this disease. Management of scleroderma-related end-stage renal disease requires some form of renal replacement therapy. Survival up to 18 months has been reported in one patient on continuous ambulatory peritoneal dialysis. Surviving for more than 1 year on automated peritoneal dialysis has not been reported. We report a patient with scleroderma-related end-stage renal disease treated with automated peritoneal dialysis with steady state control of uremia and hypertension at 18 months of follow-up.

Downloads

Download data is not yet available.

Author Biography

  • Malleshappa Pavan, Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India
    senior registrar, department of nephrology

Downloads

Published

2010-04-19

Issue

Section

CASE REPORT | Dialysis

How to Cite

Management of Scleroderma-related End-stage Renal Disease With Automated Peritoneal Dialysis. (2010). Iranian Journal of Kidney Diseases, 4(2), 162-163. https://www.ijkd.org/index.php/ijkd/article/view/261